Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heartbeam Inc (NQ: BEAT )

2.180 -0.080 (-3.54%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 198,851
Open 2.200
Bid (Size) 2.090 (5)
Ask (Size) 2.240 (3)
Prev. Close 2.260
Today's Range 2.020 - 2.281
52wk Range 1.120 - 6.740
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Granted Key Patent for Use in Innovative System Designed to Help Evaluate Cardiac Symptoms
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-52.61%
-52.61%
1 Month
-3.54%
-3.54%
3 Month
-37.71%
-37.71%
6 Month
-56.75%
-56.75%
1 Year
+50.34%
+50.34%

More News

Read More
HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System
From HeartBeam, Inc.
Via Business Wire
Recap: HeartBeam Q1 Earnings
Via Benzinga
Heartbeam Inc. (NASDAQ: BEAT) Near the Top of Equities by Percentage Gain on 3/20
Via Investor Brand Network
Topics Credit Cards
Exposures Interest Rates
Earnings Preview For HeartBeam
Via Benzinga
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces FDA 510(k) Submission of HeartBeam AIMIGo(TM) Solution
Via Investor Brand Network
Exposures Product Safety
HeartBeam Announces FDA Submission of HeartBeam AIMIGo™ VECG System
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2023 Financial Report, Corporate Updates
Via Investor Brand Network
Exposures Product Safety
HeartBeam Reports First Quarter 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire
$25 Million Capital Raise Completed to Support Commercialization of Unique 3-D Telehealth Technology for Heart Attack Detection and Rapid Response: HeartBeam, Inc. (NASDAQ: BEAT)
Via Get News
Topics Credit Cards
Exposures Interest Rates Product Safety
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes $25M Capital Raise to Achieve Upcoming Milestones, Extend Cash Runway
Via Investor Brand Network
HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial Guidance
From HeartBeam, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised to Offer Timely Solution amid a ‘Smoldering Public Health Crisis’
Via Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised to Enable Expedited Care for Heart Attack Patients
Via Investor Brand Network
HeartBeam Inc. (NASDAQ: BEAT) Focuses on CV Solutions as Study Shows CV Disease Rising Among Young Adults
Via Investor Brand Network
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q4, FY 2022 Financial Report, Corporate Updates
Via Investor Brand Network
Topics Earnings Intellectual Property
Exposures Financial Intellectual Property Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
HeartBeam Reports Fourth Quarter and Full Year 2022 Financial Results
From HeartBeam, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Acquires LIVEMOR Assets
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
HeartBeam Announces Acquisition of LIVMOR Assets
From HeartBeam, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.